tirzepatide lyf FDA approves tirzepatide, Eli Lilly's new type 2 diabetes drug, and the company shares an estimated price Tirzepatide | DirectMeds
Description
When Is a Better Time to Start
In the study, participants with a responsive genetic score had an 82% increase in the likelihood of acheiving weight loss with a GLP-1 medication.[ref] Another study showed that GLP1 receptor variants are associated with greater weight loss on GLP-1 RA drugs.[ref] Common genetic variants in the GLP1R (GLP-1 receptor) gene impact weight and type 2 diabetes risk
Tirzepatide itself is not known to cause drowsiness or sleepiness as a direct side effect
Copying numbers from the internet without context can be misleading
